Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.

BMC Cancer 2015 Mar 28;15:193. Epub 2015 Mar 28.

Department of Obstetrics and Gynecology, University Medical Center Freiburg, Hugstetterstr. 55, Freiburg, 79106, Germany.

Background: Since recent studies revealed the feasibility to detect blood-based microRNAs (miRNAs, miRs) in breast cancer (BC) patients a new field has been opened for circulating miRNAs as potential biomarkers in BC. In this pilot study, we evaluated to our knowledge for the first time whether distinct pattern of urinary miRNAs might be also applicable as innovative biomarkers for BC detection.

Methods: Urinary miRNA expression levels of nine BC-related miRNAs (miR-21, miR-34a, miR-125b, miR-155, miR-195, miR-200b, miR-200c, miR-375, miR-451) from 24 untreated, primary BC patients and 24 healthy controls were quantified by realtime-PCR. The receiver operating characteristic analyses (ROC) and logistic regression were calculated to assess discriminatory accuracy.

Results: Significant differences were found in the expression of four BC-associated miRNAs quantified as median miRNA expression levels. Urinary miR-155 levels were significantly higher in BC patients compared to healthy controls (1.49vs.0.25; p < 0.001). In contrast, compared to healthy controls, BC patients exhibited significantly lower urinary expression levels of miR-21 (2.27vs.5.07; p < 0.001), miR-125b (0.71vs.1.62; p < 0.001), and miR-451 (0.02vs.0.59 p = 0.004), respectively. The ROC including all miRNAs as well as the group of the four significant deregulated miRNAs separated BC patients from healthy controls with a very high (area under the receiver operating characteristic curve [AUC] = 0.932) and high accuracy (AUC = 0.887), respectively.

Conclusions: We were able to demonstrate for the first time the feasibility to detect distinct BC-dependent urinary miRNA profiles. The expression levels of four urinary miRNAs were specifically altered in our cohort of BC patients compared to healthy controls. This distinct pattern offers the possibility for a specific discrimination between healthy women and primary BC patients. This sustains the potential role of urinary miRNAs as non-invasive innovative urine-based biomarkers for BC detection.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1190-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383066PMC
March 2015
22 Reads

Publication Analysis

Top Keywords

cancer patients
8
breast cancer
8
healthy controls
8
expression levels
8
mirna expression
8
mirnas
5
applicable innovative
4
mirnas applicable
4
accuracyresults differences
4
biomarkers detectionmethods
4
urinary mirna
4
detectionmethods urinary
4
urinary mirnas
4
innovative biomarkers
4
differences expression
4
evaluated knowledge
4
bc-associated mirnas
4
study evaluated
4
pilot study
4
expression bc-associated
4

References

(Supplied by CrossRef)

BP Lewis et al.
Cell 2005

S Sandhu et al.
Semin Oncol 2011

SB Thorsen et al.
Cancer J 2012

L Mulrane et al.
Cancer Res 2013

M Jung et al.
Clin Chem 2010

MD Mattie et al.
Molecular cancer 2006

SK Ajit et al.
Sensors (Basel) 2012

A Turchinovich et al.
Nucleic Acids Res 2011

H Mlcochova et al.
Urol Onco 2014

S Asaga et al.
Clin Chem 2011

MA Cortez et al.
Nat Rev Clin Oncol 2011

Similar Publications